Denali Therapeutics (DNLI) Amortizatization of Intangibles (2017 - 2026)
Denali Therapeutics has reported Amortizatization of Intangibles over the past 9 years, most recently at $929000.0 for Q4 2025.
- Quarterly Amortizatization of Intangibles rose 16.56% to $929000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.6 million through Dec 2025, up 203.17% year-over-year, with the annual reading at $3.6 million for FY2025, 203.17% up from the prior year.
- Amortizatization of Intangibles was $929000.0 for Q4 2025 at Denali Therapeutics, up from $900000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $11.5 million in Q2 2023 and troughed at -$2.7 million in Q3 2021.
- The 5-year median for Amortizatization of Intangibles is $742500.0 (2022), against an average of $966500.0.
- Year-over-year, Amortizatization of Intangibles tumbled 5528.57% in 2021 and then skyrocketed 2448.88% in 2023.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$2.4 million in 2021, then surged by 158.8% to $1.4 million in 2022, then soared by 706.5% to $11.5 million in 2023, then plummeted by 93.09% to $797000.0 in 2024, then rose by 16.56% to $929000.0 in 2025.
- Per Business Quant, the three most recent readings for DNLI's Amortizatization of Intangibles are $929000.0 (Q4 2025), $900000.0 (Q3 2025), and $900000.0 (Q2 2025).